Purchase Order HHSN272201800153P

<p>The National Institute of Allergy and Infectious Diseases issued a $48,429.19 delivery order to Revvity Health Sciences, Inc. on September 3, 2015, for a MICROBETA2 with 2 detectors under the GSA Schedule for Scientific Equipment and Services (FSS-66).</p> <p>Place of performance is Bethesda, Maryland. The order has a firm fixed price and an ultimate completion date of August 31, 2019. No set-aside was used.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) valued at $7,944.00 on October 23, 2017, with a completion date of November 2, 2017. Place of performance is Bethesda, Maryland. The order is a firm fixed-price commercial purchase with no set-aside designation.</p>

Revvity Health Sciences, Inc., a division of Revvity Inc. Medical Imaging, LLC, has been awarded a $15,771 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide an annual service agreement for a Celigo microplate reader. The place of performance will be in Bethesda, Maryland. The period of performance is from December 28, 2023 through December 27, 2024. No subcontractors or set aside designations were indicated....

This firm fixed price purchase order was awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to Revvity Health Sciences, Inc. for $27,923.58. The contract is for annual renewal of two service plans for Microbeta2 Lumijet instruments located at the NIH Vaccine Research Center in Bethesda, Maryland, running from January 15, 2024 to January 14, 2025. Specifically, Revvity Health Sciences will provide a Gold Service Plan for a Microbeta2 Lumijet...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Firm Fixed Price Purchase Order to Revvity Health Sciences, Inc. for a GENE ASSAY SYSTEM 1000ML with a potential value of $13,959.00. The contract has a completion date of September 28, 2018. Revvity Health Sciences, Inc. is a for-profit manufacturer of medical imaging products and services that has received numerous prime contracts and subcontracts from...

This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Revvity Health Sciences, Inc. (a subsidiary of Revvity Inc.) for a fundamental service agreement to provide laboratory equipment. The award, valued at $14,865.60, has an ultimate completion date of October 31, 2015. The contract was not set aside for any specific business size or type. Revvity Health Sciences is a for-profit...

Revvity Health Sciences, Inc., a division of Revvity Inc. Medical Imaging, LLC, has been awarded a firm fixed price purchase order valued at fourteen thousand six hundred fifteen dollars ($14,615) by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases. The contract calls for Revvity Health Sciences to provide ALPHALISA HIV P24 (HS) KITS (AMBIS #2184099) with performance taking place in Shelton, Connecticut over the...

The National Institute of Allergy and Infectious Diseases awarded a purchase order to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) for $125,670 on July 2, 2019. The order is firm fixed price with an ultimate completion date of July 31, 2020. Work is performed in Shelton, Connecticut. The solicitation was posted June 18, 2019 and closed the same day as award. No set-aside applied. The purchase order covers the BRITELITE PLUS product line, consistent with Revvity's core...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) on October 24, 2018, for $22,488.00 in maintenance services for a Zephyr workstation. Performance location is Shelton, Connecticut. The order was to be completed by October 25, 2019, under firm fixed-price terms.</p>

The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) awarded a firm-fixed-price purchase order contract to Revvity Health Sciences, Inc., a subsidiary of Revvity Inc., for preventive maintenance of the IVIS-TWINBROOK 3 facility in Bethesda, Maryland. The $19,467.03 contract has an ultimate completion date of November 30, 2012 and does not utilize a set-aside designation. Revvity Health Sciences, Inc. is a for-profit medical imaging...